On Thursday, October 15, 2020, LifeSciences BC presented an opportunity to join members of Gowling WLG’s Life Sciences Group, along with Ben Thiede of STEMCELL Technologies, together as they explored strategies for managing IP risks and opportunities in an innovative life sciences enterprise. For any organization invested in research and development, IP landscaping and Freedom to Operate (FTO) analysis can serve as a vital roadmap as you bring your product to life – and finally to market.

Introduction: LifeSciences BC’s President & CEO, Wendy Hurlburt

Moderator: Lisa Thorne, Partner at Gowling WLG

Panelists:

• Brian Kingwell, Partner at Gowling WLG
• Edith Penty Geraets, Associate at Gowling WLG
• Ben Thiede, Senior Business Development Officer at STEMCELL Technologies

Thank you to our event sponsor